Report Detail

The biocellular therapy industry includes upstream cell storage, midstream cell technology development, and downstream cell therapy.
The downstream of the biological cell therapy industry chain - cell therapy, the implementation of the main body is the top three hospitals; there are two types of downstream industry models: one for the top three hospitals to carry out this business, the other for the top three hospitals and enterprises cooperation, the company provides Technical services and technical support, the hospital provides a clinical platform to implement treatment behavior.
In 2019, the market size of Biotherapeutics Cell Line is 56 million US$ and it will reach 100 million US$ in 2025, growing at a CAGR of 7.3% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biotherapeutics Cell Line.

This report studies the global market size of Biotherapeutics Cell Line, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biotherapeutics Cell Line production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Becton Dickinson
Beckman Coulter
Boehringer Ingelheim Pharma
CMC Biologics
Catalent
Lonza Group
ProBioGen
Partec
SAFC
Sony Biotechnology
Selexis
Thermo Fisher Scientific

Market Segment by Product Type
Single Cell Cloning
Transfection and Selection

Market Segment by Application
Cancer
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Biotherapeutics Cell Line status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biotherapeutics Cell Line manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biotherapeutics Cell Line are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Biotherapeutics Cell Line Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Single Cell Cloning
      • 1.3.3 Transfection and Selection
    • 1.4 Market Segment by Application
      • 1.4.1 Global Biotherapeutics Cell Line Market Share by Application (2019-2025)
      • 1.4.2 Cancer
      • 1.4.3 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Biotherapeutics Cell Line Production Value 2014-2025
      • 2.1.2 Global Biotherapeutics Cell Line Production 2014-2025
      • 2.1.3 Global Biotherapeutics Cell Line Capacity 2014-2025
      • 2.1.4 Global Biotherapeutics Cell Line Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Biotherapeutics Cell Line Market Size CAGR of Key Regions
      • 2.2.2 Global Biotherapeutics Cell Line Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Biotherapeutics Cell Line Capacity by Manufacturers
      • 3.1.2 Global Biotherapeutics Cell Line Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Biotherapeutics Cell Line Revenue by Manufacturers (2014-2019)
      • 3.2.2 Biotherapeutics Cell Line Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Biotherapeutics Cell Line Market Concentration Ratio (CR5 and HHI)
    • 3.3 Biotherapeutics Cell Line Price by Manufacturers
    • 3.4 Key Manufacturers Biotherapeutics Cell Line Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Biotherapeutics Cell Line Market
    • 3.6 Key Manufacturers Biotherapeutics Cell Line Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Single Cell Cloning Production and Production Value (2014-2019)
      • 4.1.2 Transfection and Selection Production and Production Value (2014-2019)
    • 4.2 Global Biotherapeutics Cell Line Production Market Share by Type
    • 4.3 Global Biotherapeutics Cell Line Production Value Market Share by Type
    • 4.4 Biotherapeutics Cell Line Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Biotherapeutics Cell Line Consumption by Application

    6 Production by Regions

    • 6.1 Global Biotherapeutics Cell Line Production (History Data) by Regions 2014-2019
    • 6.2 Global Biotherapeutics Cell Line Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Biotherapeutics Cell Line Production Growth Rate 2014-2019
      • 6.3.2 United States Biotherapeutics Cell Line Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Biotherapeutics Cell Line Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Biotherapeutics Cell Line Production Growth Rate 2014-2019
      • 6.4.2 European Union Biotherapeutics Cell Line Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Biotherapeutics Cell Line Import & Export
    • 6.5 China
      • 6.5.1 China Biotherapeutics Cell Line Production Growth Rate 2014-2019
      • 6.5.2 China Biotherapeutics Cell Line Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Biotherapeutics Cell Line Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Biotherapeutics Cell Line Consumption by Regions

    • 7.1 Global Biotherapeutics Cell Line Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Biotherapeutics Cell Line Consumption by Type
      • 7.2.2 United States Biotherapeutics Cell Line Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Biotherapeutics Cell Line Consumption by Type
      • 7.3.2 European Union Biotherapeutics Cell Line Consumption by Application
    • 7.4 China
      • 7.4.1 China Biotherapeutics Cell Line Consumption by Type
      • 7.4.2 China Biotherapeutics Cell Line Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Biotherapeutics Cell Line Consumption by Type
      • 7.5.2 Rest of World Biotherapeutics Cell Line Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Becton Dickinson
      • 8.1.1 Becton Dickinson Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.1.4 Biotherapeutics Cell Line Product Introduction
      • 8.1.5 Becton Dickinson Recent Development
    • 8.2 Beckman Coulter
      • 8.2.1 Beckman Coulter Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.2.4 Biotherapeutics Cell Line Product Introduction
      • 8.2.5 Beckman Coulter Recent Development
    • 8.3 Boehringer Ingelheim Pharma
      • 8.3.1 Boehringer Ingelheim Pharma Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.3.4 Biotherapeutics Cell Line Product Introduction
      • 8.3.5 Boehringer Ingelheim Pharma Recent Development
    • 8.4 CMC Biologics
      • 8.4.1 CMC Biologics Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.4.4 Biotherapeutics Cell Line Product Introduction
      • 8.4.5 CMC Biologics Recent Development
    • 8.5 Catalent
      • 8.5.1 Catalent Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.5.4 Biotherapeutics Cell Line Product Introduction
      • 8.5.5 Catalent Recent Development
    • 8.6 Lonza Group
      • 8.6.1 Lonza Group Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.6.4 Biotherapeutics Cell Line Product Introduction
      • 8.6.5 Lonza Group Recent Development
    • 8.7 ProBioGen
      • 8.7.1 ProBioGen Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.7.4 Biotherapeutics Cell Line Product Introduction
      • 8.7.5 ProBioGen Recent Development
    • 8.8 Partec
      • 8.8.1 Partec Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.8.4 Biotherapeutics Cell Line Product Introduction
      • 8.8.5 Partec Recent Development
    • 8.9 SAFC
      • 8.9.1 SAFC Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.9.4 Biotherapeutics Cell Line Product Introduction
      • 8.9.5 SAFC Recent Development
    • 8.10 Sony Biotechnology
      • 8.10.1 Sony Biotechnology Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Biotherapeutics Cell Line
      • 8.10.4 Biotherapeutics Cell Line Product Introduction
      • 8.10.5 Sony Biotechnology Recent Development
    • 8.11 Selexis
    • 8.12 Thermo Fisher Scientific

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Biotherapeutics Cell Line Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Biotherapeutics Cell Line Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Biotherapeutics Cell Line Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Biotherapeutics Cell Line Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Biotherapeutics Cell Line Production Forecast by Type
      • 9.7.2 Global Biotherapeutics Cell Line Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Biotherapeutics Cell Line Sales Channels
      • 10.2.2 Biotherapeutics Cell Line Distributors
    • 10.3 Biotherapeutics Cell Line Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Biotherapeutics Cell Line. Industry analysis & Market Report on Biotherapeutics Cell Line is a syndicated market report, published as Global (United States, European Union and China) Biotherapeutics Cell Line Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biotherapeutics Cell Line market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,433.60
      765,650.40
      1,020,867.20
      273,486.40
      410,229.60
      546,972.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report